Korro Bio is trading 6.7% down at $12.90, despite broader markets and biotechnology trading higher; the immediate catalyst is unclear.
- No confirmed company-specific announcement dated September 17, 2026 was identified.
- The latest reported filing was a September 11 inducement grant covering options for three new employees.